Stay updated on RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial

Sign up to get notified when there's something new on the RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    7 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the ongoing clinical trial for the Corvia Atrial Shunt Device in heart failure patients with mildly reduced or preserved ejection fraction. This change may reflect new data or developments in the study protocol.
    Difference
    0.1%
    Check dated 2024-06-06T14:29:34.000Z thumbnail image
  7. Check
    22 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifically focusing on chronic symptomatic heart failure and associated conditions. This change provides specific inclusion and exclusion criteria for potential study participants.
    Difference
    35%
    Check dated 2024-05-22T20:55:39.000Z thumbnail image
  8. Check
    44 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2024-04-30T22:15:54.000Z thumbnail image

Stay in the know with updates to RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial page.